David Eansor

2022

In 2022, David Eansor earned a total compensation of $3.2M as Former President, Protein Sciences at Bio-Techne, a 50% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$757,492
Option Awards$1,499,825
Salary$448,141
Stock Awards$499,808
Other$4,140
Total$3,209,406

Eansor received $1.5M in option awards, accounting for 47% of the total pay in 2022.

Eansor also received $757.5K in non-equity incentive plan, $448.1K in salary, $499.8K in stock awards and $4.1K in other compensation.

Rankings

In 2022, David Eansor's compensation ranked 1,132nd out of 5,756 executives tracked by ExecPay. In other words, Eansor earned more than 80.3% of executives.

ClassificationRankingPercentile
All
1,132
out of 5,756
80th
Division
Manufacturing
543
out of 3,133
83rd
Major group
Chemicals And Allied Products
198
out of 1,419
86th
Industry group
Drugs
178
out of 1,320
87th
Industry
Biological Products, Except Diagnostic Substances
39
out of 291
87th
Source: SEC filing on September 14, 2022.

Eansor's colleagues

We found five more compensation records of executives who worked with David Eansor at Bio-Techne in 2022.

2022

Charles Kummeth

Bio-Techne

Chief Executive Officer

2022

James Hippel

Bio-Techne

Chief Financial Officer

2022

Brenda Furlow

Bio-Techne

General Counsel

2022

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

2022

William Geist

Bio-Techne

President, Protein Sciences

News

You may also like